Grand Rounds

Department of Pediatrics, Centro Hospitalar de Leiria, Leiria, Portugal

Address for Correspondence: Beatriz Simões Vala, Rua de Santo André 2410-197 Leiria, Portugal. Email:

Keywords: Toxoplasmosis, Congenital, rebound effect, serology, toxoplasma gondii

Clinical Problem :
A male newborn who was the third child of a non-consanguineous couple was referred for further management on the fourth day of life. Asymptomatic toxoplasmosis seroconversion was detected at 21st week of pregnancy in the pregnant lady with maternal toxoplasma IgG level of 88.9 IU/mL (positive range > 8.8 IU/mL), IgG avidity test of 0.18 (low) and IgM of 10.3 IU/mL (positive range > 8.0 IU/mL). Oral Spiramycin (3 g /day) was started in the mother five weeks later. Amniotic fluid Toxoplasma gondii PCR was negative and routine antenatal ultrasound scans were normal. Lower segment caesarean section delivery was done due to two previous caesarean section deliveries, at the gestational age of 38 weeks, with an Apgar score at the 1st and 5th minutes of 9/10. Post-delivery, clinical examination of the child was normal. Birth weight was 3650 g, length 51 cm and head circumference 34.7 cm, all appropriate for gestational age according to the Fenton Growth Charts. Cord blood analysis revealed toxoplasma IgG level of 96.5 IU/mL (positive range > 8.8 IU/mL) and IgM < 3 IU/mL (negative range < 6.0 IU/mL). Placental inoculation in mice was done and toxoplasma antigen at 10 days and three weeks were negative.
The infant maintained a regular follow-up with serial serological monitoring. Hearing assessment in the first days of life was unremarkable. Serial serologies for T. gondii (Table 1) showed decreasing IgG and negative IgM until six months of age. By this time, a tenfold IgG elevation was noted, with a negligible IgM level increase, confirming congenital toxoplasmosis. Oral Pyrimethamine 1 mg/kg once a day, sulphadiazine 100 mg/kg/day divided every 12 hours and Folinic acid 5 mg three times a week were started. Serum T. gondii PCR was negative. Cranial ultrasonography and ophthalmologic evaluation were normal. Brainstem auditory evoked potentials revealed no audiologic problems. On treatment, neutropenia was detected twice, after one and five months of therapy, with absolute neutrophil count of 900 cells/cumm and 700 cells/cumm respectively, justifying treatment adjustment. Pyrimethamine was reduced from daily to three times a week and the dose of Folinic acid was doubled until neutrophil count surpassed 1000 cells/cumm. During the 12 months of therapeutic course, the child remained without symptoms. Seven months after the end of the treatment, IgG serological rebound was found, in which toxoplasma IgG levels increased from 44.8 IU/mL at 21 months to 1480.0 IU/mL at 27 months. Toxoplasma IgM remained negative. Ophthalmological and hearing reassessment showed no alterations. Despite the serological changes, the infant was asymptomatic.

Note: IgG: immunoglobulin G; IgM: immunoglobulin M; IU/mL: international units per millilitre. (IgG range: negative < 7.2 IU/mL, doubtful 7.2 – 8.8 IU/mL, positive > 8.8 IU/mL. IgM range: negative < 6 IU/mL, doubtful 6 – 8 IU/mL, positive > 8.0 IU/mL.)

Table 1. Serial toxoplasma specific IgG and IgM serological titres

How to treat the serologic rebound in this case?
How to treat the serologic rebound in this case?
Disclaimer: The information given by is provided by medical and paramedical & Health providers voluntarily for display & is meant only for informational purpose. The site does not guarantee the accuracy or authenticity of the information. Use of any information is solely at the user's own risk. The appearance of advertisement or product information in the various section in the website does not constitute an endorsement or approval by Pediatric Oncall of the quality or value of the said product or of claims made by its manufacturer.
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0